Depression MD – Milford, Connecticut Ketamine Clinics, Spravato Clinics

✓ Last verified: February 13, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Depression MD is a psychiatry practice in Milford that offers Ketamine-Assisted Psychotherapy (KAP) alongside IV ketamine infusions and Spravato® (esketamine) treatment. Led by Dr. Harding, the clinic combines medication management, TMS therapy, and ketamine treatments under one roof. Sessions are monitored by a psychiatrist and medical professionals over 90–120 minutes, providing a more comprehensive approach than infusion-only clinics.

HealingMaps Take: Depression MD offers one of the more comprehensive treatment menus in the Milford area, with KAP, IV ketamine, Spravato®, and TMS all available through a single practice. Dr. Harding is praised by patients as genuinely caring and passionate about her work. Reviews are mixed overall — the ketamine and KAP services receive positive feedback, while some patients have noted that standard medication management appointments can feel brief. For patients seeking a psychiatrist-led practice that integrates ketamine therapy into a broader treatment plan, Depression MD is a solid Connecticut option.

Market Position: Depression MD is a Spravato-certified clinic in the Milford metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.

Depression MD Ketamine Cost Calculator

Ketamine Protocols Compared — What’s Offered at Depression MD

Industry pricing reference. Depression MD has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

What to Expect at Your First Depression MD Appointment

1. Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (203) 701-9737 to schedule.
2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Depression MD clinical team.
3. First treatment session — supervised IV ketamine infusion in a private treatment room, lasting approximately 60–90 minutes (40-minute infusion + recovery). Sessions are held at 472 Wheelers Farm Rd, Milford, CT 06461. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your IV session.

What to Ask on Your Depression MD Consult Call

• How long has the Depression MD clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
• Walk me through Depression MD’s Spravato prior authorization process versus your IV ketamine cash-pay or superbill workflow — which is the better fit for my insurance situation?
• Have you handled Anthem BCBS Connecticut, Cigna, or Aetna Spravato authorizations — and what’s the typical PA timeline?
• Is the therapist who guides KAP sessions independently licensed, and how long are integration sessions after the dosing portion?
• What does Depression MD recommend for patients who don’t respond to the standard 6-session acute series?

Milford Ketamine Market Snapshot

Sources: CDC PLACES 2023 (Connecticut, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.

• Adult depression in Connecticut: N/A
• Frequent mental distress (14+ days per month): N/A
• Adults lacking health insurance: N/A
• Recent Milford-area inquiries to HealingMaps: A growing stream of Connecticut residents have recently contacted us seeking ketamine care

Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.

From the 2026 Ketamine Industry Report

64.8% of patients surveyed believe at-home ketamine is “a bad idea” — the largest consensus finding in our patient survey, favoring in-clinic supervised treatment. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.

Patient Questions about Depression MD

This 5-question summary is matched to the protocols and conditions Depression MD treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

What ketamine protocols does Depression MD offer?

Depression MD offers Spravato, IV ketamine and KAP — a 3-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.

Does Depression MD offer Spravato (esketamine)?

Yes — Depression MD offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.

Does Depression MD offer ketamine-assisted psychotherapy (KAP)?

Yes — Depression MD offers KAP, which combines ketamine dosing with structured psychotherapy during the dissociative window. KAP sessions are longer than standalone infusions and priced accordingly. A reasonable consult question: whether KAP is delivered by a single integrated provider, or by a separate therapist working with the prescribing clinician.

Is Depression MD suited for treatment-resistant depression?

Depression MD treats depression via Spravato (FDA-approved for TRD), IV ketamine (off-label, evidence-based), and KAP for trauma-anchored depression. The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Can Depression MD help with anxiety disorders?

Yes — Depression MD treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.

View all REMS-certified Spravato clinics in Connecticut and across the United States.